FDA approves Comirnaty as first COVID vaccine

Regulatory NewsRegulatory NewsAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaRegulatory Intelligence/Policy